1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends

Advancement in Liquid Dosage Excipients (Parenteral & Transdermal)

  • July 2014
  • 88 pages
  • Frost & Sullivan
Report ID: 2244741

Summary

Table of Contents

The Increasing Number of Therapeutic Drugs, Need for Immediate Relief Drive the Growth of Parenteral and Transdermal Excipients

This study covers in detail the parenteral and transdermal excipients used in the pharmaceutical industry. We have observed that the growing prescription of biologicals that are almost exclusively administered by parenteral routes drives the market growth. Convenience and immediate therapeutic benefits have spurred the growth of transdermal products, which has in-turn increased transdermal excipients. The benefits provided by both product forms are expected to gain market share in the next five years.

Executive Summary
-In 2013, the global parenteral excipients segment generated a revenue of $ million, and it is predicted to grow to become $ billion by the year 2018 with a CAGR of %.
-The total global parenteral finished products market is estimated to be worth $billion. Parenteral finished products include vials with sterile liquids or powders to be reconstituted for injection; prefilled syringes, cartridges, or pens; single-dosage vials; multiple-dosage vials; and infusion bottles.
-The transdermal excipients segment is predicted to generate $ million by 2018, growing at a CAGR of %. This market is currently generating a global revenue of $ million.
-The high growth of biological drugs that are exclusively administered only through the parenteral route is driving market growth.
oVial injections make up about % of all parenteral units prescribed globally, with the remainder composed of prefilled syringes and other forms such as cartridges, auto injectors, and pens. Diabetes takes the lion’s share of more than % of injectable units.
-Usage of transdermal patches has recently increased multifold in developed regions such as the United States and Western Europe because of its convenience of use and sustained therapeutic effect. The growth of transdermal is accelerating the growth of transdermal excipients.
-The main restraint hindering market growth is increased cost of production, which is leading to high-priced parenteral and transdermal excipients. High price hinders the adaptation of the product by pharmaceutical companies.
-The key market participants in this market are BASF, Dow Chemicals, and Gattefosse. Other market participants include Cargill and Abitech.

Market Overview—Parenteral Excipients
Parenteral Drugs:
-Parenteral drugs are pyrogen-free, sterile liquid or solid dosages. They may contain or more active ingredients in the form of single as well as multiple dosages.
-These drugs are administered in the form of injections, intravenous infusions, or implants, and they tend to have improved bioavailability compared to oral solid dosages.
-The first-pass metabolism of a parenteral enhances its bioavailability.
-Excipients such as buffering agents, solubilizing agents, anti-microbial preservatives, and carbohydrate excipients are used exclusively in formulating parenteral drugs.
-Biologic parenterals was a $ billion market globally in 2011. About % of indications for biologic parenterals arise from prescriptions for inflammatory diseases, cancers, infectious diseases, and diabetes.
-The total global parenterals market was estimated to be worth $ billion in 2011. Products in this market can be classified as newer biopharmaceuticals that are almost exclusively available as parenterals and conventional injectables.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Ahmad helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Controlled-release Technologies: Established and Emerging Markets

  • $ 6650
  • Industry report
  • May 2017
  • by BCC Research

• The global market for controlled-release barrier materials reached $960 million in 2016 and should reach nearly $1.3 billion in 2021, registering a compound annual growth rate (CAGR) of 5.7% through ...

BRIC Biopsy Devices Market Outlook to 2023

  • $ 5995
  • Industry report
  • May 2017
  • by GlobalData

BRIC Biopsy Devices Market Outlook to 2023 Summary GlobalData’s new report, "BRIC Biopsy Devices Market Outlook to 2023", provides key market data on the BRIC Biopsy Devices market. The report provides ...

Asia-Pacific Biopsy Devices Market Outlook to 2023

  • $ 5995
  • Industry report
  • May 2017
  • by GlobalData

Asia-Pacific Biopsy Devices Market Outlook to 2023 Summary GlobalData’s new report, "Asia-Pacific Biopsy Devices Market Outlook to 2023", provides key market data on the Asia-Pacific Biopsy Devices ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.